Chiropractors in Lisbon, IA Accepting Medicare
2 Chiropractors found. Showing 1 - 2
 Dr. Jared Christopher Nolz, D.C. Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 309 W Highway 30, Lisbon, IA 52253 Phone: 319-455-2910 Fax: 319-455-2165 |
 Nolz Chiropractic Clinic Pc Chiropractor Medicare: Medicare Enrolled Practice Location: 309 W Highway 30, Lisbon, IA 52253 Phone: 319-455-2910 Fax: 319-455-2165 |
News Archive
Aptiv Solutions, Cancer Genetics partner to deliver comprehensive solutions for clinical trials in oncology
Aptiv Solutions and Cancer Genetics, Inc. (CGI) have formed a strategic partnership focused on delivering comprehensive solutions to biopharmaceutical and medical device firms conducting clinical trials for oncology therapeutics.
Developing safe imaging tools to better identify the risk of preterm birth
Dr. Helen Feltovich is a high-risk obstetrician, also known as a maternal-fetal doctor, and she sees women when they are at risk of a preterm birth. Preterm birth recently surpassed infectious diseases as the leading cause of death in children under five years old. It's a critical global problem, with no easy fix.
Disrupting mTORC1 protein complex extends lifespan
One of the secrets to a longer, healthier life is simply to eat less. When subjected to calorie restriction (CR), typically defined as a 20-40% reduction in caloric intake with corresponding maintenance of proper nutrition, animals in labs not only live longer, but also have improved insulin sensitivity and glucose tolerance, both of which decline during aging.
Children of heavy drinkers have elevated risk of several adverse experiences
The children of parents who drink alcohol heavily have an elevated risk of a number of adverse experiences, including mental health disorders, hospitalizations and criminal behavior, according to a new review in the Journal of Studies on Alcohol and Drugs.
Cell Therapeutics presents data on PIX301 trial of Pixuvri for relapsed or refractory, aggressive NHL
Cell Therapeutics, Inc. today reported exploratory analyses of the data at study completion from the Company's pivotal PIX301 trial of Pixuvri, the first randomized controlled trial in patients with relapsed or refractory, aggressive non-Hodgkin's lymphoma.
› Verified 1 days ago